Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Troilus Files NI 43-101 Technical Report for the Troilus Project’s Feasibility Study
-
Subsea 7 S.A. cancels treasury shares
-
Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on International Neonatal Screening Day
-
CryptoSafe Unveils Safe Pay: A Game-Changer in Cryptocurrency Payment Solutions
-
Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
-
OTC Markets Group Welcomes Golden Metal Resources PLC to OTCQX
-
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
-
Asset Entities Inc. Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
-
Plug to Receive Federal Clean Hydrogen Production Tax Credit at Georgia Hydrogen Facility
-
OTC Markets Group Welcomes Endo, Inc. to OTCQX
-
Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors
-
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
-
Amwell Announces Reverse Stock Split
-
Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
-
Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility
-
RAIR Technologies Empowers Developers to Build Web3 Applications through India’s Largest Hackathon
-
Crown Crafts Announces Financial Results for Fourth Quarter and Full Year Fiscal 2024
-
AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS
-
Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU
-
OKX Marketplace and Layer3 to Give Away 50,000 Polygon-Based 'Layer3 x OKX Genesis' NFTs
-
OKX Wallet Now Integrated with DeltaTrade
-
Tri Pointe Homes, Inc. Announces Second Quarter 2024 Earnings Release and Conference Call Date
-
ARS Pharmaceuticals Announces EURneffy (adrenaline nasal spray) Recommended for Approval by CHMP for Emergency Treatment of Allergic Reactions (anaphylaxis)
-
OKX Wallet Now Integrated with Mitosis, an Ecosystem-Owned Liquidity Layer 1 Blockchain
-
Roche’s Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO)
-
Issue of Equity and Total Voting Rights
-
Resolutions of Valoe’s Annual General Meeting, Decision on a Follow-up Meeting, and Organising of the Board of Directors
-
Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on International Neonatal Screening Day
-
Man Group PLC : Form 8.3 - International Paper Company
-
CryptoSafe Unveils Safe Pay: A Game-Changer in Cryptocurrency Payment Solutions
-
OTC Markets Group Welcomes Golden Metal Resources PLC to OTCQX
-
Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
-
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
-
Asset Entities Inc. Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
-
Plug to Receive Federal Clean Hydrogen Production Tax Credit at Georgia Hydrogen Facility
-
OTC Markets Group Welcomes Endo, Inc. to OTCQX
-
Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors
-
23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
-
Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
-
Amwell Announces Reverse Stock Split
-
RAIR Technologies Empowers Developers to Build Web3 Applications through India’s Largest Hackathon
-
Esperion Announces Monetization of European Royalties and Concurrent Payoff and Termination of Existing Revenue Interest Facility
-
CHMP recommends EU approval of Roche’s PiaSky for people with PNH, a rare, life-threatening blood condition
-
Apellis Plans to Seek Re-Examination Following Negative CHMP Opinion for Pegcetacoplan for Geographic Atrophy (GA) in the EU
-
Man Group PLC : Form 8.3 - Smith (DS) plc
-
Man Group PLC : Form 8.3 - Quanex Building Products Corporation
-
OKX Marketplace and Layer3 to Give Away 50,000 Polygon-Based 'Layer3 x OKX Genesis' NFTs
-
Man Group PLC : Form 8.3 - Bellway plc
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Lok’n Store Group plc
